中文名稱(chēng):兔抗GRIN2B(Ab-1303) 多克隆抗體
Background: |
NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. In concert with DAPK1 at extrasynaptic sites, acts as a central mediator for stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity inducing injurious Ca2+ influx through them, resulting in an irreversible neuronal death By similarity. |
Applications: |
WB |
Name of antibody: |
GRIN2B(Ab-1303) |
Immunogen: |
Synthesized non-phosphopeptide derived from human GRIN2B around the phosphorylation site of serine 1303 (Q-H-S(p)-Y-D). |
Full name: |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
Synonyms: |
MRD6; NR2B; hNR3; GluN2B; NMDAR2B |
SwissProt: |
Q13224 |
WB Predicted band size: |
166 kDa |
WB Positive control: |
NIH/3T3 cells lysates |
WB Recommended dilution: |
500-3000 |